Loading viewer...
earnings
Format: PDF earnings
Aurora Cannabis reports record adjusted EBITDA of $3.4M in Q2 2024 with four consecutive quarters of positive EBITDA, driven by $400M in cost efficiencies and a strong net cash position exceeding $200M. The company focuses on achieving positive free cash flow in 2024 while pursuing opportunistic M&A and leveraging its diversified presence across 12 global cannabis markets.
investor_presentation
16 Pages
earnings
17 Pages
Absolute Software
Xponential Fitness Q2 2024 Financial Results
earningsearnings
14 Pages
XPONENTIAL FITNESS
Alembic Pharmaceuticals Q1 FY2026 Earnings Presentation
earningsearnings
22 Pages
Alembic Pharmaceuticals